Transchem P/E Ratio
Current P/E Ratio
55.57
High Valuation
Very High - High growth expectations or significantly overvalued
Transchem (TRANSCHEM) P/E ratio is 55.57 (High), EPS (TTM) ₹3.51, current price ₹175.65 on BSE — Very High - High growth expectations or significantly overvalued. Browse Transchem annual reports for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/E Ratio
55.57
Current Price
₹175.65
EPS (TTM)
₹3.51
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.85
Sector Median
29.34
Sector Rank
#11 of 190
Sector Percentile
5.8%
TRANSCHEM P/E Ratio — Valuation Signal & Historical Context
Transchem P/E 55.57 — signal: Overvalued. Analyse TRANSCHEM shareholding pattern to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 55.57, suggesting caution for new investments
- Trading at premium to sector average PE of 49.85
TRANSCHEM vs Healthcare Peers — P/E Ratio Comparison
Transchem P/E 55.57 vs Healthcare average 49.85, median 29.34 — range 1.0–869.57.
Sector Average
49.85
Sector Median
29.34
Lowest P/E
1.0
Highest P/E
869.57
Companies
190
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.0 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹61 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |